Sector News

Nestlé's new chief expected to drive health expansion through M&A

June 30, 2016
Food & Drink

Nestlé’s surprise appointment of former Fresenius chief Ulf Mark Schneider as its new CEO could trigger a series of acquisitions by the Swiss food giant to further its ambitions in nutrition and medical foods.

Shares in the company rose 3.5 percent to 73.60 Swiss francs on Tuesday as analysts and investors digested the previous day’s announcement of Nestlé’s first external hire as CEO in nearly a century and the potential for expansion of its relatively small but highly profitable health and wellness business.

In his 13 years at the helm of German health care company Fresenius, Schneider oversaw a series of deals that brought a twelvefold increase in net income. Nestlé, meanwhile, has been laboring with faltering progress in its traditional food business, missing growth targets for the past three years

“It is striking that Nestlé hasn’t gone for a CEO from the consumer goods sector,” said Jean-Philippe Bertschy, an analyst at Bank Vontobel in Zurich.

“It shows Nestlé really wants to transform the business and not just do a little bit of health and wellness on the side.”

With estimated sales of about 4 billion Swiss francs ($4.09 billion) out of Nestlé’s total 88.8 billion francs in 2015, the health business is seen as faster growing and more profitable than Nestlé’s traditional food and beverage operations, which include Nescafe instant coffee and KitKat chocolate bars.

The integration of Nestlé’s health science and skin health divisions, which will report directly to Schneider rather than operating as standalone businesses, was described as a positive development by Bertschy.

GROWTH DRIVER
Health products, including medical foods for patients with conditions such as Alzheimers’ and gastrointestinal problems, have become an increasing focus for Nestlé in recent years, with a string of acquisitions and investments.

Analysts say growth in the business was 7.6 percent in 2015, compared with 4.2 percent rate for the group as a whole, while Nestlé is aiming to lift annual sales of health products to as high as 10 billion francs.

The health operations also bring stronger profit margins. The group’s overall operating profit margin was 15.1 percent in 2015 and analysts estimate the health business could eventually achieve margins above 20 percent.

“The bulk of Nestlé’s business will remain in food for the foreseeable future, but it shows health is an area that Nestlé wants to grow further,” Zuercher Kantonalbank analyst Patrik Schwendimann said, adding that Schneider’s appointment could trigger more acquisitions in health and wellness.

Investors were also bullish on a shift towards health products.

“Nestlé’s focus on health can help the company counterbalance tough conditions for the rest of the business, said Gilles Bey, a fund manager at Valiant Bank, which manages a 71 million franc position in Nestlé.

Kepler Cheuvreux analyst Jon Cox was equally upbeat on Schneider, who will officially take charge at the start of next year after an introductory period starting in September.

“This is a clear signal that Nestlé is going to stick to its 5 percent to 6 percent growth target,” Cox said.

“Schneider knows the health business very well. Merger and acquisition activity is more likely to be in the health area in the future.” ($1 = 0.9768 Swiss francs)

By John Revill

Source: Reuters

comments closed

Related News

January 22, 2023

Danone unveils plan to cut methane emissions

Food & Drink

The company expects to eliminate 1.2 billion tons carbon dioxide equivalent of methane emissions by the end of the decade. The company says that it already reduced its methane emissions by around 14% between 2018 and 2020.

January 22, 2023

US researchers land US$2.4M to turn food waste into “affordable” bioplastics

Food & Drink

The “first-of-its-kind” pilot project will develop and demonstrate an affordable modular bioprocessing system to produce biodegradable bioplastics from food waste diverted from landfills. The three-year grant will test the scalability and feasibility of the conversion on a national and global scale.

January 22, 2023

Arkeon partners with ICL to transform CO2 into proteins

Food & Drink

Arkeon is allying with specialty mineral giant ICL to support the scaling of its fermentation bioprocess that converts CO2 into the 20 proteinogenic essential amino acids needed in human nutrition. The process, hailed as carbon negative, is based on the use of archaea, a group of microorganisms that naturally feeds off the greenhouse gas.

How can we help you?

We're easy to reach